Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nazir Ismail

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
The Lancet. Respiratory Medicine|July 14, 2018
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort studyKathryn Schnippel, Norbert Ndjeka, Gary Maartens, et al.
Emerging Microbes & Infections|February 8, 2023
Designing molecular diagnostics for current tuberculosis drug regimensSophia B Georghiou, Margaretha de Vos, Kavindhran Velen, et al.
BMJ Global Health|November 5, 2025
Targeted next-generation sequencing for drug-resistant tuberculosis diagnosis: implementation considerations for bacterial load, regimen selection and diagnostic algorithm placementSophia B Georghiou, Nestani Tukvadze, Camilla Rodrigues, et al.
BMC Public Health|November 24, 2023
Determining the risk-factors for molecular clustering of drug-resistant tuberculosis in South AfricaHalima Said, Elizabeth Kachingwe, Yasmin Gardee, et al.
Journal of Clinical Microbiology|April 15, 2016
Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid ResistanceRuvandhi R Nathavitharana, Doris Hillemann, Samuel G Schumacher, et al.
Frontiers in Microbiology|December 21, 2016
Correlation of <i>rpoB</i> Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in <i>Mycobacterium tuberculosis</i> in an HIV/AIDS Endemic Setting, South AfricaIvy Rukasha, Halima M Said, Shaheed V Omar, et al.
The Lancet. Infectious Diseases|February 9, 2025
Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trialNazir Ismail, Harry Moultrie, Judith Mwansa-Kambafwile, et al.
Plos One|July 7, 2015
Incidence and Geographic Distribution of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal Province, South AfricaJennifer R Lim, Neel R Gandhi, Thuli Mthiyane, et al.
Open Forum Infectious Diseases|May 26, 2023
A Systematic Review on the Safety of <i>Mycobacterium tuberculosis</i>-Specific Antigen-Based Skin Tests for Tuberculosis Infection Compared With Tuberculin Skin TestsYohhei Hamada, Irina Kontsevaya, Elena Surkova, et al.
BMC Microbiology|May 28, 2021
Distribution and Clonality of drug-resistant tuberculosis in South AfricaHalima Said, John Ratabane, Linda Erasmus, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
The Lancet. Respiratory Medicine|July 14, 2018
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort studyKathryn Schnippel, Norbert Ndjeka, Gary Maartens, et al.
Emerging Microbes & Infections|February 8, 2023
Designing molecular diagnostics for current tuberculosis drug regimensSophia B Georghiou, Margaretha de Vos, Kavindhran Velen, et al.
BMJ Global Health|November 5, 2025
Targeted next-generation sequencing for drug-resistant tuberculosis diagnosis: implementation considerations for bacterial load, regimen selection and diagnostic algorithm placementSophia B Georghiou, Nestani Tukvadze, Camilla Rodrigues, et al.
BMC Public Health|November 24, 2023
Determining the risk-factors for molecular clustering of drug-resistant tuberculosis in South AfricaHalima Said, Elizabeth Kachingwe, Yasmin Gardee, et al.
Journal of Clinical Microbiology|April 15, 2016
Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid ResistanceRuvandhi R Nathavitharana, Doris Hillemann, Samuel G Schumacher, et al.
Frontiers in Microbiology|December 21, 2016
Correlation of <i>rpoB</i> Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in <i>Mycobacterium tuberculosis</i> in an HIV/AIDS Endemic Setting, South AfricaIvy Rukasha, Halima M Said, Shaheed V Omar, et al.
The Lancet. Infectious Diseases|February 9, 2025
Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trialNazir Ismail, Harry Moultrie, Judith Mwansa-Kambafwile, et al.
Plos One|July 7, 2015
Incidence and Geographic Distribution of Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal Province, South AfricaJennifer R Lim, Neel R Gandhi, Thuli Mthiyane, et al.
Open Forum Infectious Diseases|May 26, 2023
A Systematic Review on the Safety of <i>Mycobacterium tuberculosis</i>-Specific Antigen-Based Skin Tests for Tuberculosis Infection Compared With Tuberculin Skin TestsYohhei Hamada, Irina Kontsevaya, Elena Surkova, et al.
BMC Microbiology|May 28, 2021
Distribution and Clonality of drug-resistant tuberculosis in South AfricaHalima Said, John Ratabane, Linda Erasmus, et al.
Pageof 8